Evidence map›Paper›PMID 41472929›Full record

ArticleProstate international2025

Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum.

Michael Frumer, Iyad Khamaisi, Guy Levenberg, Gherman Creiderman, Ron Gilad, Sagi A Shpitzer, Tzach Aviv, Muhammad Krenawi, Shayel Bercovich, Nadav Dekel and 10 more

Abstract read
In one paragraph

Article in Prostate international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Michael FrumerUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Iyad KhamaisiUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Guy LevenbergUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Gherman CreidermanUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Ron GiladUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Sagi A ShpitzerUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Tzach AvivUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Muhammad KrenawiUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Shayel BercovichUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Nadav DekelUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Hadar TamirUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Tomer HasdaiUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Yossi VenturaUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Niv SegalUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Hen HendelUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Liran ZieberUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Jack BanielUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
David LifshitzUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Abd E DarawshaUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.
Yaron EhrlichUrology division, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A bladder diverticulum is a source of infections, urinary stones, and malignancy. Until recent years, patients suffering from large obstructive prostate and diverticulum were treated with open surgery, which also allowed diverticulectomy. The transition to a closed approach has led to diverticulum preservation. The clinical implications of this preservation strategy have not been sufficiently studied. Materials and methods: A retrospective comparison was made between holmium laser enucleation of the prostate (HoLEP) patients with a diverticulum (≥2 cm) and HoLEP patients without any diverticulum. For each patient with a diverticulum, two patients without a diverticulum who were operated on around the same time were matched (1:2). Patients operated on until March 2022 were included to allow for a relatively long follow-up period. Results: Out of 602 HoLEP patients, 32 (5%) had a diverticulum Conclusions: HoLEP is an effective treatment method for patients with bladder outlet obstruction and concomitant bladder diverticulum. By effectively relieving the bladder outlet obstruction, HoLEP can avoid the need for more invasive surgical interventions.

Indexed as

BladderBladder outlet obstructionDiverticulumLower urinary tract symptomsProstatectomyProstatic hyperplasiaTransurethral

Identifiers

PMID41472929
PMCPMC12746239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.